Also trades as: PCLO.V (TSXV) · $vol 0M
PCLOF OTC
PharmaCielo Ltd.
1W: -6.9%
1M: -23.6%
3M: -29.5%
YTD: -44.6%
1Y: +51.1%
3Y: -75.4%
5Y: -96.4%
$0.04
-0.00 (-2.78%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$881K
+55.3% ▲
Capital Expenditures
$4
+0.0% ▲
5Y CAGR: -94.0%
Free Cash Flow
-$881K
+55.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$286K
+233.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$27M | -$15M | -$16M | -$9M | $407K |
| Depreciation & Amort. | $1M | $2M | $1M | $1M | $994K |
| Stock-Based Comp. | $7M | $2M | $2M | $1M | $27K |
| Change in Working Capital | -$8M | -$2M | $2M | $794K | -$2M |
| Other Non-Cash Items | $6M | $3M | $6M | $4M | -$740K |
| Operating Cash Flow | -$20M | -$10M | -$5M | -$2M | -$881K |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$522K | -$15K | $0 | $0 |
| Acquisitions (Net) | -$1M | $0 | $0 | $0 | $5M |
| Investment Purchases | -$546K | -$204K | $0 | $0 | $0 |
| Investment Sales | $777K | $0 | $179K | $0 | $0 |
| Other Investing | $546K | $167K | $228K | $41K | $2M |
| Investing Cash Flow | -$2M | -$558K | $392K | $41K | $7M |
| — Financing Activities — | |||||
| Net Debt Issuance | $5M | $5M | $5M | $469K | -$3M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $47K | $123K | $0 | $2M | -$562K |
| Financing Cash Flow | $18M | $5M | $5M | $2M | -$5M |
| Net Change in Cash | -$4M | -$5M | -$111K | $86K | $286K |
| Cash End of Period | $5M | $173K | $62K | $148K | $289K |
| Free Cash Flow | -$21M | -$10M | -$5M | -$2M | -$881K |